Impact of the implementation of a telemedicine program on patients diagnosed with asthma.

Eva Maria Guix-Comellas, Núria Fabrellas, Héctor Cabrerizo-Carreño, Mariana Muñoz-Esquerre, Salud Santos Pérez, Ana Maria Romero-Ortiz

Journal: BMC pulmonary medicine 2024;24(1):32

PMID: 38216971

Free Full Text on BioMed Central View on PubMed

Abstract

BACKGROUND

Asthma is one of the most common respiratory ailments worldwide. Despite broad understanding of the illness and of the available therapeutic options for it, patients with serious asthma suffer poor monitoring of their illness in 50% of cases.

AIM

To assess the impact of the implementation of a mobile application (ESTOI) to control asthma in patients diagnosed with the illness, their adherence to treatment, and their perceived quality of life.

METHODOLOGY

Randomized clinical trial with 52 weeks' follow-up of patients with asthma seen in a specialized hospital for their treatment in Spain. Some 108 included patients will be divided into two groups. The intervention group will undergo more exhaustive follow-up than normal, including access to the ESTOI application, which will have various categories of attention: control of symptoms, health recommendations, current treatment and personalized action plan, PEF record, nutritional plan, and chat access with a medical team. The asthma control questionnaire ACT is the main assessment variable. Other variables to be studied include an adherence test for the use of inhalers (TAI), the number of exacerbations, maximum exhalation flow, exhaled nitric oxide test, hospital anxiety and depression scale, asthma quality-of-life questionnaire, forced spirometry parameters (FVC, FEV1, and PBD), and analytic parameters (eosinophilia and IGE). The data will be collected during outpatient visits.

TRIAL REGISTRATION

This trial has registered at ClinicalTrials.gov (Identifier: NCT06116292).

Address: Bellvitge University Hospital, Department of Pulmonary Medicine, L'Hospitalet de Llobregat, Catalunya, ES, Spain.; Department of Fundamental and Medico-Surgical Nursing, Nursing School, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalunya, ES, Spain.; Pneumology Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Catalunya, ES, Spain.; Bellvitge University Hospital, Department of Pulmonary Medicine, L'Hospitalet de Llobregat, Catalunya, ES, Spain. [email protected].; Pneumology Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Catalunya, ES, Spain. [email protected].; Facultat de Medicina i Ciències de la Salut, University of Barcelona, L'Hospitalet de Llobregat, Catalunya, ES, Spain. [email protected].; Bellvitge University Hospital, Department of Pulmonary Medicine, L'Hospitalet de Llobregat, Catalunya, ES, Spain.; Pneumology Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Catalunya, ES, Spain.; Facultat de Medicina i Ciències de la Salut, University of Barcelona, L'Hospitalet de Llobregat, Catalunya, ES, Spain.; Bellvitge University Hospital, Department of Pulmonary Medicine, L'Hospitalet de Llobregat, Catalunya, ES, Spain.; Department of Public Health, Faculty of Medicine and Health Sciences, School of Nursing, University of Barcelona, Barcelona, Catalunya, ES, Spain.; Nursing Research Group, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Catalunya, ES, Spain.; Department of Fundamental and Medico-Surgical Nursing, Nursing School, Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Catalunya, ES, Spain.

DOI: 10.1186/s12890-024-02843-y

Link outs

Free resources

Full Text Sources:

Medical:

MeSH Terms: Humans, Quality of Life, Asthma, Nebulizers and Vaporizers, Spirometry, Telemedicine